CalciMedica (CALC) Assets (2019 - 2026)
CalciMedica's (CALC) quarterly Assets came in at $8.6 million in Q1 2026, down 66.04% YoY from $25.3 million in Q1 2025, and down 36.66% on a QoQ basis from $13.6 million in Q4 2025.
CalciMedica (CALC) Assets (2019 - 2026) Analysis & Trends
CalciMedica (CALC) has 8 years of Assets data on file, last reported at $8.6 million in Q1 2026.
- Quarterly Assets fell 66.04% year-over-year to $8.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 million (down 66.04% YoY) and the FY2025 annual result came in at $13.6 million, down 31.34% from the prior year.
- Assets fell to $8.6 million in Q1 2026, from $13.6 million in the prior quarter.
- In the past five years, Assets ranged from a high of $60.6 million in Q1 2022 to a low of $3.3 million in Q4 2022.
- A 5-year average of $24.2 million and a median of $19.8 million in 2024 frame the typical range for Assets.
- Annual changes were most pronounced in 2022 — Assets tumbled 95.15% — and 2023, when it soared 263.84%.
- Tracing CALC's Assets over 5 years: stood at $3.3 million in 2022, then soared by 263.84% to $12.2 million in 2023, then surged by 62.45% to $19.8 million in 2024, then slumped by 31.34% to $13.6 million in 2025, then tumbled by 36.66% to $8.6 million in 2026.
- The last three Assets figures came in at $8.6 million (Q1 2026), $13.6 million (Q4 2025), and $14.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | CalciMedica | 9.80 Mn | -8.82 Mn | - | 19.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.50 Mn |
| Mar 31, 2026 | 8.61 Mn |
| Dec 31, 2025 | 13.59 Mn |
| Sep 30, 2025 | 14.91 Mn |
| Jun 30, 2025 | 19.08 Mn |
| Mar 31, 2025 | 25.35 Mn |
| Dec 31, 2024 | 19.79 Mn |
| Sep 30, 2024 | 16.21 Mn |
| Jun 30, 2024 | 21.05 Mn |
| Mar 31, 2024 | 27.13 Mn |
| Dec 31, 2023 | 12.19 Mn |
| Sep 30, 2023 | 15.85 Mn |
| Jun 30, 2023 | 20.25 Mn |
| Mar 31, 2023 | 34.67 Mn |
| Dec 31, 2022 | 3.35 Mn |
| Sep 30, 2022 | 45.36 Mn |
| Jun 30, 2022 | 54.02 Mn |
| Mar 31, 2022 | 60.59 Mn |
| Dec 31, 2021 | 69.09 Mn |
| Sep 30, 2021 | 76.64 Mn |